3 completed, 1 unknown. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow Norovirus Infections: new trials by email Literature Review of Norovirus Infections trials Research Report on Norovirus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers Open label Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose, Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose, Bivalent GII.4/GI.1 medium dose vaccine 1×10 to the power 11 IU/dose - Norovirus Infections | Phase 2 | Completed | Vaxart | 135 | 2023-01-26 | 2025-04-15 |
| Norovirus Challenge Study VXA-G1.1-NN, Placebo Tablets, Norovirus GI.1 Norwalk Virus Inoculum - Norovirus Infections | Phase 1 / Phase 2 | Completed | Vaxart | 165 | 2021-12-27 | 2025-11-05 |
| Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha) middle-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine, high-dose Norovirus Bivalent (GI.1 / GII.4) Vaccine, placebo - Norovirus Infections, Norwalk Gastroenteritis | Phase 2 | Unknown | National Vaccine and Serum Institute, China | 1716 | 2021-06-30 | 2022-10-28 |
| Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines VXA-G1.1-NN - Norovirus Infections | Phase 1 / Phase 2 | Completed | Vaxart | 30 | 2021-04-30 | 2024-05-22 |
Infections (4) · RNA Virus Infections (4) · Virus Diseases (4)
Vaccines (1)
Vaxart (3) · National Vaccine and Serum Institute, China (1)
United States (3) · China (1)
James Cummings, MD (2) · Helen Paguntalan, MD (1)